🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 774.29 -0.4% NASDAQ 100: 752.71 -0.7% Dow Jones: 534.08 -0.5%

Msh Capital Advisors - Q4 2025 13F Filings

MS

Msh Capital Advisors LLC

CIK: 0002056306
Address: Arizona Scottsdale 23350 N Pima Rd
$468.04 M
Portfolio Value
274
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 08/10/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025
1. AAPL Apple
+$35.96 M
2. TSLA Tesla
+$3.51 M
3. QGRO American Century Us Quality Growth Etf
+$2.52 M
4. ABBV Abbvie
+$2.04 M
5. NVDA Nvidia Corporation
+$1.87 M

Top Sells

Q4 2025
1. GH Guardant Health
−$604,260.09
2. RTO Rentokil Initial PLC
−$553,278
3. C Citigroup
−$477,462
4. QUAL Ishares Msci Usa Quality Factor Etf
−$444,528.86
5. STX Seagate Technology Holdings PLC
−$409,229.63

Asset Allocation

Stocks/ETFs
+26.40%
$467.76 M 99.94%
Options
$0 0.00%
Debt
$0 0.00%
Other
-90.79%
$282,349 0.06%

Sector Allocation (Stocks)

Msh Capital Advisors Q4 2025 Filing Summary

Msh Capital Advisors LLC filed its 13F report for Q4 2025 on February 09, 2026. The portfolio totaled 468.04 M reflecting a +25.44% change from the prior quarter, spanning 274 assets. The top 10 holdings comprised 28.6% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 39 new positions and 5 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Msh Capital Advisors’s Q4 2025 Filing

Msh Capital Advisors submitted their Form 13F-HR for the Q4 2025 period on 02/09/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Msh Capital Advisors reported a managed portfolio value of 468.04 M, consisting of 297 individual positions.

This page displays the raw filing documents. To see which stocks Msh Capital Advisors bought or sold during Q4 2025, please visit Msh Capital Advisors's Portfolio Analysis page.